Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | APP | P05067 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | CCR2 | P41597 | 1/20 | 0.44 |
| ▸ | SNCA | P37840 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | CFTR | P13569 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6087453 | 0.89 | RECQL (0.49) | NPC1HSP90AA1RECQLALDH1A1CCR2 | |
| SCHEMBL15845476 | 0.80 | CFTR (0.43) | NPC1HSP90AA1RECQLAPPALDH1A1 | |
| SCHEMBL24130455 | 0.80 | ALDH1A1 (0.43) | RECQLALDH1A1MAPTGAAMEN1 | |
| SCHEMBL2875153 | 0.79 | KMT2A (0.50) | ALDH1A1CCR2MAPTL3MBTL1MEN1 | |
| SCHEMBL2875151 | 0.79 | KMT2A (0.50) | ALDH1A1CCR2MAPTL3MBTL1MEN1 | |
| SCHEMBL15845448 | 0.77 | RECQL (0.49) | NPC1HSP90AA1RECQLALDH1A1CCR2 | |
| SCHEMBL15845658 | 0.76 | ALDH1A1 (0.44) | NPC1HSP90AA1RECQLALDH1A1CCR2 | |
| SCHEMBL13139569 | 0.75 | ALDH1A1 (0.44) | ALDH1A1CCR2POLBMAPTL3MBTL1 | |
| SCHEMBL31347625 | 0.75 | TXNRD1 (0.42) | NPC1ALDH1A1POLBMAPTHTT | |
| SCHEMBL25293342 | 0.74 | RECQL (0.51) | RECQLALDH1A1CCR2POLBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103059065-B | Azo metal complex and preparation method thereof | SHANGHAI TOYOU DIGITAL TECH CO LTD | 2015-04-22 | — | — | CN | claimed |
| US-12037636-B2 | Polynucleotide synthesis method, kit and system | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2024-07-16 | — | — | US | disclosed |
| US-20220396818-A1 | POLYNUCLEOTIDE SYNTHESIS METHOD, KIT AND SYSTEM | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2022-12-15 | — | — | US | disclosed |
| US-20220213537-A1 | POLYNUCLEOTIDE SYNTHESIS METHOD, KIT AND SYSTEM | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2022-07-07 | — | — | US | disclosed |
| US-20220177937-A1 | POLYNUCLEOTIDE SYNTHESIS METHOD, KIT AND SYSTEM | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2022-06-09 | — | — | US | disclosed |
| US-20220177938-A1 | POLYNUCLEOTIDE SYNTHESIS METHOD, KIT AND SYSTEM | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2022-06-09 | — | — | US | disclosed |
| US-20210388432-A1 | POLYNUCLEOTIDE SYNTHESIS METHOD, KIT AND SYSTEM | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2021-12-16 | — | — | US | disclosed |
| US-20210324436-A1 | METHODS AND REAGENTS FOR SYNTHESISING POLYNUCLEOTIDE MOLECULES | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2021-10-21 | — | — | US | disclosed |
| US-20210198710-A1 | POLYNUCLEOTIDE SYNTHESIS METHOD, SYSTEM AND KIT | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2021-07-01 | — | — | US | disclosed |
| US-10927394-B2 | Methods and reagents for synthesising polynucleotide molecules | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2021-02-23 | — | — | US | disclosed |
| WO-2020016606-A1 | POLYNUCLEOTIDE SYNTHESIS METHOD, KIT AND SYSTEM | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2020-01-23 | — | — | WO | disclosed |
| WO-2020016605-A1 | POLYNUCLEOTIDE SYNTHESIS METHOD, KIT AND SYSTEM | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2020-01-23 | — | — | WO | disclosed |
| WO-2020016604-A1 | POLYNUCLEOTIDE SYNTHESIS METHOD, KIT AND SYSTEM | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2020-01-23 | — | — | WO | disclosed |
| US-20190352687-A1 | METHODS AND REAGENTS FOR SYNTHESISING POLYNUCLEOTIDE MOLECULES | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2019-11-21 | — | — | US | disclosed |
| WO-2019150134-A1 | POLYNUCLEOTIDE SYNTHESIS METHOD, KIT AND SYSTEM | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2019-08-08 | — | — | WO | disclosed |
| WO-2018134616-A1 | METHODS AND REAGENTS FOR SYNTHESISING POLYNUCLEOTIDE MOLECULES | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2018-07-26 | — | — | WO | disclosed |
| US-20100190768-A1 | NOVEL FUSED PYROLE DERIVATIVE | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2010-07-29 | — | — | US | disclosed |
| CN-101321726-A | Novel fused pyrrole derivative | DAINIPPON SUMITOMO PHARMA CO (JP) | 2008-12-10 | — | — | CN | disclosed |
| EP-1930320-A1 | NOVEL FUSED PYRROLE DERIVATIVE | Dainippon Sumitomo Pharma Co., Ltd. (JP) | 2008-06-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100190768-A1 | NOVEL FUSED PYROLE DERIVATIVE | NR3C1, NR3C2, NR0B1 | NPC1 4800/4885HSP90AA1 3432/4885RECQL 2262/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.